Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

Expert Rev Anticancer Ther. 2012;12(1):41-49. © 2012 Expert Reviews Ltd. Uterine serous cancer (USC) is a highly aggressive variant of endometrial cancer. USC is ...

Initially considered benign, recent studies have revealed that APA can have a high rate of recurrence and may precede the development of endometrial carcinoma. This has led to a growing interest ...

Zentalis Pharmaceuticals, Inc.’s ZNTL share price has surged by 31.29%, which has investors questioning if this is right time to sell.

Merck and Eisai said on Friday a combination of their cancer therapies failed to extend the lives of patients with a type of ...

D tumoroid models transform cancer research, accurately reflecting tumor biology and enabling effective drug testing and ...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.

The Food and Drug Administration (FDA) previously granted the combination regular approval for patients with advanced endometrial carcinoma that is not microsatellite instability-high (MSI-H) or ...

Imfinzi recommended for approval in European Union for the treat of adults with limited-stage small cell lung cancer ...